Literature DB >> 16570014

How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis.

Keryn A Williams1, Adrian J Esterman, Christine Bartlett, Helene Holland, Ngaere B Hornsby, Douglas J Coster.   

Abstract

BACKGROUND: In a large patient cohort, we investigated long-term corneal graft outcome, risk factors for graft failure, and whether corneal graft survival had improved over time.
METHODS: Records of 10,952 full-thickness corneal grafts with associated archival follow-up were examined within a prospectively-maintained, national database of 13,831 records, with follow-up extending for up to 18 years. Kaplan-Meier survival analysis was used to indicate variables of interest for Cox proportional hazards regression analysis. A model clustered by individual patient to control for inter-eye or inter-graft dependence was constructed to identify variables best predicting penetrating corneal graft failure.
RESULTS: Probability of corneal graft survival was 0.86 at 1 year, 0.73 at 5 years, 0.62 at 10 years, and 0.55 at 15 years. Graft survival did not improve over a 15-year timeframe. Variables predicting graft failure in multivariate analysis included transplant centre, donor age, preoperative diagnosis, number of previous ipsilateral grafts, lens status, history of corneal neovascularisation, ocular inflammation or raised intraocular pressure in the grafted eye, requirement for anterior vitrectomy, graft size, early suture removal, postoperative events including graft neovascularisation, rise in intraocular pressure, and rejection episodes, type of treatment for raised intraocular pressure, and arrangements for recipient follow-up. A further 11 variables showing a significant influence on graft survival in univariate analysis were not included in the final Cox model.
CONCLUSION: The long-term results of corneal transplantation are no better than for other forms of transplantation and have shown no measurable improvement over the past 15 years.

Entities:  

Mesh:

Year:  2006        PMID: 16570014     DOI: 10.1097/01.tp.0000185197.37824.35

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  47 in total

1.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

2.  Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.

Authors:  Amir R Hajrasouliha; Toshinari Funaki; Zahra Sadrai; Takaaki Hattori; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Corneal graft rejection in African Americans at Howard University Hospital.

Authors:  Larry Ferdinand; Vanessa Ngakeng; Robert A Copeland
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

4.  Management of Corneal Graft Rejection - A Case Series Report and Review of the Literature.

Authors:  Pho Nguyen; Felise Barte; Shuntaro Shinada; Samuel C Yiu
Journal:  J Clin Exp Ophthalmol       Date:  2010-09-29

5.  Development of Selective Lamellar Keratoplasty within an Asian Corneal Transplant Program: The Singapore Corneal Transplant Study (An American Ophthalmological Society Thesis).

Authors:  Donald Tan; Marcus Ang; Anshu Arundhati; Wei-Boon Khor
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 6.  Immune privilege of corneal allografts.

Authors:  Jerry Y Niederkorn; D Frank P Larkin
Journal:  Ocul Immunol Inflamm       Date:  2010-06       Impact factor: 3.070

7.  Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study.

Authors:  Steven P Dunn; Robin L Gal; Craig Kollman; Dan Raghinaru; Mariya Dontchev; Christopher L Blanton; Edward J Holland; Jonathan H Lass; Kenneth R Kenyon; Mark J Mannis; Shahzad I Mian; Christopher J Rapuano; Walter J Stark; Roy W Beck
Journal:  Cornea       Date:  2014-10       Impact factor: 2.651

8.  Efficacy of topical bevacizumab in high-risk corneal transplant survival.

Authors:  Nasir Bhatti; Umair Qidwai; Munawar Hussain; Asif Kazi
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

9.  Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.

Authors:  Ajay Sharma; Daniel I Bettis; John W Cowden; Rajiv R Mohan
Journal:  Mol Vis       Date:  2010-04-23       Impact factor: 2.367

10.  [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty].

Authors:  N Bailly; I Dunewa; P Schlattmann; P W Rieck
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.